They just raised $28m
Hardly a shambles.
Bubs is/was at 30% capacity of its relatively new Deloraine facility, so allowing for huge growth into 2021Yr via new Vita bubs product and expected China growth from new SAMR accreditation
Ann: MOU to Manufacture SAMR Infant Formula in China, page-161
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $102.7M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.8¢ | 11.5¢ | $172.6K | 1.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 2507097 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 2646668 | 30 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| BUB (ASX) Chart |